Key Stats for Mettler-Toledo Stock
- This Week Performance: -3.6%
- 52-Week Range: $946.7 to $1,525.2
- Current Price: $1,316.7
What Happened?
Mettler-Toledo‘s service business quietly crossed $1 billion in annual revenue for the first time in 2025, reframing MTD less as a pure instruments maker and more as a recurring-revenue platform, with shares trading at $1,316.71 against a median analyst target of $1,500.
On February 5, CEO Patrick Kaltenbach delivered Q4 results with sales of $1.13 billion, beating the $1.105 billion consensus, while raising full-year 2026 adjusted EPS guidance to $46.05–$46.70 from the prior $45.35–$46.00 range.
Adjusted EPS grew 8% to $13.36 in Q4, powered by broad-based local currency growth of 5%, with Product Inspection surging 7% organically and Food Retail jumping 19%, validating the company’s mid-market innovation push.
CFO Shawn Vadala stated on the Q4 earnings call that “we penetrated about 1/3” of the roughly $3 billion serviceable installed base, directly linking the $1 billion service milestone to a multi-year share capture opportunity still in early stages.
Meanwhile, newly appointed board member Michael J. Tokich, the former 17-year CFO of STERIS plc, joined effective February 5, adding institutional-grade financial discipline as MTD navigates tariff headwinds that cut 130 basis points from 2025 operating margins.
With onshoring investments described by management as a “2027 and beyond” catalyst, MTD’s automation and digitalization portfolio, paired with a deepening service annuity and above-average emerging market growth now exceeding 18% of revenues, positions the company to compound earnings well above current market assumptions.
Wall Street’s Take on MTD Stock
That Q4 earnings beat, paired with the raised 2026 EPS guidance of $46.05–$46.70, gives MTD’s revenue recovery trajectory a firmer foundation, with the $1 billion service milestone anchoring a more durable, recurring earnings stream.
The fundamental case strengthens further: consensus estimates project revenue reaching $4.23 billion in 2026, up 5%, while normalized EPS climbs to $46.49, an 8.8% gain that marks the sharpest growth rate since 2022’s 16.6%.
As of March 3, 13 analysts cover MTD with 5 buys, 1 outperform, 8 holds, and 1 underperform, carrying a mean price target of $1,501.38, implying 14% upside from the current $1,316.71.
The target range spans $1,200 on the low end to $1,700 on the high end, with the bull case hinging on onshoring-driven industrial demand materializing in 2027 and the bear case reflecting persistent tariff pressure and soft European PMIs.
What Does the Valuation Model Say?
The TIKR valuation model prices MTD at $1,808.43 under mid-case assumptions, a 37.3% total return over 4.8 years at a 6.8% annualized IRR, against a stock currently trading $491 below that target.
The market appears to be discounting MTD’s compounding service business, which has only penetrated 1/3 of its $3 billion serviceable installed base, leaving two-thirds of that recurring revenue opportunity entirely unpriced at current levels.
A 10-year EPS CAGR of 12.7% sits against a stock that has returned just 4.7% annually over the past year, a disconnect that grows harder to justify as the $46.05–$46.70 EPS guidance range confirms the earnings engine is intact.
Management’s confidence signal is the $825–$875 million share repurchase program for 2026, a concrete capital allocation commitment that tells investors the board sees the same valuation gap the model does.
However, tariffs remain the live threat; gross tariff costs hit operating profit by $50 million and 130 basis points in 2025, and any escalation beyond current assumed levels would directly compress the 60–70 basis point margin expansion embedded in 2026 guidance.
Q1 2026 adjusted EPS, guided at $8.60–$8.75, will be the first real test of whether customer caution is temporary or structural, particularly in core industrial and laboratory segments.
MTD is a compounding precision instruments franchise trading at a meaningful discount to intrinsic value, and the Q1 2026 earnings print will tell investors whether the recovery is already underway.
Should You Invest in Mettler-Toledo International Inc.?
The only way to really know is to look at the numbers yourself. TIKR gives you free access to the same institutional-quality financial data that professional analysts use to answer exactly that question.
Pull up MTD stock and you’ll see years of historical financials, what Wall Street analysts expect for revenue and earnings in the quarters ahead, how valuation multiples have moved over time, and whether price targets are trending up or down.
You can build a free watchlist to track Mettler-Toledo International Inc. alongside every other stock on your radar. No credit card required. Just the data you need to decide for yourself.
Access Professional Tools to Analyze MTD stock on TIKR for Free →
